Bill SponsorBILLSPONSOR
Bill Sponsor
Politicians
Bills
Senate Bill 2451
115th Congress(2017-2018)
Protection from Overprescribing Act
Introduced
Introduced
Introduced in Senate on Feb 26, 2018
Overview
Text
Introduced in Senate 
Feb 26, 2018
Not Scanned for Linkage
About Linkage
Multiple bills can contain the same text. This could be an identical bill in the opposite chamber or a smaller bill with a section embedded in a larger bill.
Bill Sponsor regularly scans bill texts to find sections that are contained in other bill texts. When a matching section is found, the bills containing that section can be viewed by clicking "View Bills" within the bill text section.
Bill Sponsor is currently only finding exact word-for-word section matches. In a future release, partial matches will be included.
Introduced in Senate(Feb 26, 2018)
Feb 26, 2018
Not Scanned for Linkage
About Linkage
Multiple bills can contain the same text. This could be an identical bill in the opposite chamber or a smaller bill with a section embedded in a larger bill.
Bill Sponsor regularly scans bill texts to find sections that are contained in other bill texts. When a matching section is found, the bills containing that section can be viewed by clicking "View Bills" within the bill text section.
Bill Sponsor is currently only finding exact word-for-word section matches. In a future release, partial matches will be included.
Jump To
S. 2451 (Introduced-in-Senate)


115th CONGRESS
2d Session
S. 2451


To require the Secretary of Health and Human Services to consider State analysis and sharing of prescription drug monitoring program data in determining prescription drug monitoring program grants to States.

IN THE SENATE OF THE UNITED STATES

February 26, 2018

Mr. Cassidy introduced the following bill; which was read twice and referred to the Committee on Health, Education, Labor, and Pensions

A BILL

To require the Secretary of Health and Human Services to consider State analysis and sharing of prescription drug monitoring program data in determining prescription drug monitoring program grants to States.

Be it enacted by the Senate and House of Representatives of the United States of America in Congress assembled,

SECTION 1. Short title.

This Act may be cited as the “Protection from Overprescribing Act”.

SEC. 2. Consideration in awarding grants to support State PDMPs.

In determining whether to award a grant to a State in support of a State prescription drug monitoring program, the Secretary of Health and Human Services shall consider whether each agency of the State that administers the prescription drug monitoring program pro­ac­tively analyzes data available through the State’s prescription drug monitoring program and provides reports to law enforcement agencies, prescriber licensing boards, and other agencies describing any prescribers that repeatedly fall outside of expected norms or standard practices for the prescriber’s field.